PL1858861T3 - Hamujące HIV 2-(4-cyjanofenylo)-6-hydroksyloaminopirymidyny - Google Patents

Hamujące HIV 2-(4-cyjanofenylo)-6-hydroksyloaminopirymidyny

Info

Publication number
PL1858861T3
PL1858861T3 PL06708609T PL06708609T PL1858861T3 PL 1858861 T3 PL1858861 T3 PL 1858861T3 PL 06708609 T PL06708609 T PL 06708609T PL 06708609 T PL06708609 T PL 06708609T PL 1858861 T3 PL1858861 T3 PL 1858861T3
Authority
PL
Poland
Prior art keywords
hydroxylaminopyrimidines
cyanophenyl
compounds
hiv inhibiting
hiv
Prior art date
Application number
PL06708609T
Other languages
English (en)
Polish (pl)
Inventor
Kock Herman Augustinus De
Piet Tom Bert Paul Wigerinck
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of PL1858861T3 publication Critical patent/PL1858861T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06708609T 2005-03-04 2006-03-02 Hamujące HIV 2-(4-cyjanofenylo)-6-hydroksyloaminopirymidyny PL1858861T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101707 2005-03-04
PCT/EP2006/060407 WO2006094930A1 (en) 2005-03-04 2006-03-02 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
EP06708609A EP1858861B1 (en) 2005-03-04 2006-03-02 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines

Publications (1)

Publication Number Publication Date
PL1858861T3 true PL1858861T3 (pl) 2010-12-31

Family

ID=34938904

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06708609T PL1858861T3 (pl) 2005-03-04 2006-03-02 Hamujące HIV 2-(4-cyjanofenylo)-6-hydroksyloaminopirymidyny

Country Status (20)

Country Link
US (2) US20080214588A1 (sr)
EP (1) EP1858861B1 (sr)
JP (1) JP5118978B2 (sr)
CN (1) CN101133038B (sr)
AT (1) ATE473212T1 (sr)
AU (1) AU2006222057B2 (sr)
BR (1) BRPI0609291B1 (sr)
CY (1) CY1111102T1 (sr)
DE (1) DE602006015291D1 (sr)
DK (1) DK1858861T3 (sr)
ES (1) ES2347815T3 (sr)
HR (1) HRP20100504T1 (sr)
ME (1) ME01229B (sr)
MX (1) MX2007010744A (sr)
PL (1) PL1858861T3 (sr)
PT (1) PT1858861E (sr)
RS (1) RS51435B (sr)
RU (1) RU2401261C2 (sr)
SI (1) SI1858861T1 (sr)
WO (1) WO2006094930A1 (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2533258T3 (es) * 2005-02-18 2015-04-08 Janssen Sciences Ireland Uc Derivados de óxido de 2-(4-cianofenilamino)pirimidina que inhiben el VIH
MX2009005881A (es) 2006-12-13 2009-06-12 Hoffmann La Roche Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
EP2342186B1 (en) * 2009-06-22 2014-09-17 Emcure Pharmaceuticals Limited Process for synthesis of etravirine
US8153790B2 (en) 2009-07-27 2012-04-10 Krizmanic Irena Process for the preparation and purification of etravirine and intermediates thereof
CN101993419B (zh) * 2009-08-20 2013-01-16 浙江九洲药业股份有限公司 一种4-[(5-溴-4,6-二氯-2-嘧啶基)氨基]苯甲腈的制备方法
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
WO2011135578A1 (en) 2010-04-28 2011-11-03 Chetan Balar Composition comprising chitin and tinosporin for use in the treatment of viral diseases
US20130123498A1 (en) 2011-10-19 2013-05-16 Maja Sepelj MAJER Process for the preparation of etravirine and intermediates in the synthesis thereof
PE20242348A1 (es) 2020-02-19 2024-12-16 Pharmasyntez Agentes antivirales para el tratamiento y la prevencion de la infeccion por vih
CN117343017A (zh) * 2023-09-28 2024-01-05 四川大学 含联芳基结构的卤代二芳基嘧啶类化合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
UA56992C2 (uk) * 1995-05-08 2003-06-16 Фармація Енд Апджон Компані <font face="Symbol">a</font>-ПІРИМІДИНТІОАЛКІЛЗАМІЩЕНІ ТА <font face="Symbol">a</font>-ПІРИМІДИНОКСОАЛКІЛЗАМІЩЕНІ СПОЛУКИ
BR9611562A (pt) 1995-11-23 1999-03-02 Janssen Pharmaceutica Nv Misturas sólidas de ciclodextrinas preparadas via extrusão sob fusão
SK287270B6 (sk) * 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu
TR200200763T2 (tr) * 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
AU782948B2 (en) * 2000-05-08 2005-09-15 Janssen Pharmaceutica N.V. Prodrugs of HIV replication inhibiting pyrimidines

Also Published As

Publication number Publication date
EP1858861B1 (en) 2010-07-07
RU2007136782A (ru) 2009-04-10
US20100121060A1 (en) 2010-05-13
DK1858861T3 (da) 2010-11-08
RS51435B (sr) 2011-04-30
SI1858861T1 (sl) 2010-10-29
JP2008531658A (ja) 2008-08-14
DE602006015291D1 (de) 2010-08-19
ES2347815T3 (es) 2010-11-04
US20080214588A1 (en) 2008-09-04
BRPI0609291B1 (pt) 2022-02-08
WO2006094930A1 (en) 2006-09-14
ME01229B (me) 2013-06-20
CY1111102T1 (el) 2015-06-11
PT1858861E (pt) 2010-09-16
CN101133038A (zh) 2008-02-27
AU2006222057B2 (en) 2012-10-04
EP1858861A1 (en) 2007-11-28
ATE473212T1 (de) 2010-07-15
RU2401261C2 (ru) 2010-10-10
BRPI0609291A2 (pt) 2010-03-09
CN101133038B (zh) 2012-06-27
HRP20100504T1 (hr) 2010-10-31
JP5118978B2 (ja) 2013-01-16
MX2007010744A (es) 2007-09-12
US8119801B2 (en) 2012-02-21
AU2006222057A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
CY1111102T1 (el) 2-(4-κυανοφαινυλ)-6-υδροξυλαμινοπυριμιδινες που αναστελλουν τον hiv
ZA202209563B (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors
TW200500346A (en) HIV replication inhibiting indane substituted pyrimidines
MX2011012628A (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
SA519410865B1 (ar) مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه
HRP20040686B1 (hr) Novi heterocikliäśki spojevi koji djeluju kao inhibitori beta-laktamaza
SE0400284D0 (sv) Novel compounds
TW200736232A (en) Pyrimidine derivatives
MY139506A (en) Hiv replication inhibitors
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
MX2022012881A (es) Inhibidores de replicacion del virus de inmunodeficiencia humana.
TW200639156A (en) New compounds
TW200626561A (en) HIV inhibiting 5-substituted pyrimidines
MX2009010932A (es) Inhibidores no nucleosidos de transcriptasa inversa.
MX2009012704A (es) Inhibidores de transcriptasa inversa de no nucleosidos.
MX2019014321A (es) Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias.
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
ZA202310682B (en) Nicotinamide ripk1 inhibitors
ZA202203106B (en) Thiazole carboxamide compounds and use thereof for the treatment of mycobacterial infections
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
MX2009013865A (es) Urea y derivados carbamato como inhibidores no nucleosidicos de la transcriptasa inversa.
TW200616614A (en) A pharmaceutical composition for treating spinocerebellar ataxia
WO2025019626A3 (en) Proteosome complex inhibitors targeting clpp1p2 protease